142 related articles for article (PubMed ID: 26707367)
1. Systematic Review and Meta-Analysis: Macrolides- and Amoxicillin/Clavulanate-induced Acute Liver Injury.
Ferrer P; Amelio J; Ballarín E; Sabaté M; Vidal X; Rottenkolber M; Schmiedl S; Laporte JR; Ibáñez L;
Basic Clin Pharmacol Toxicol; 2016 Jul; 119(1):3-9. PubMed ID: 26707367
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced liver injury.
Leise MD; Poterucha JJ; Talwalkar JA
Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
[TBL] [Abstract][Full Text] [Related]
3. Hepatotoxicity by Drugs: The Most Common Implicated Agents.
Björnsson ES
Int J Mol Sci; 2016 Feb; 17(2):224. PubMed ID: 26861310
[TBL] [Abstract][Full Text] [Related]
4. Characterization of amoxicillin- and clavulanic acid-specific T cells in patients with amoxicillin-clavulanate-induced liver injury.
Kim SH; Saide K; Farrell J; Faulkner L; Tailor A; Ogese M; Daly AK; Pirmohamed M; Park BK; Naisbitt DJ
Hepatology; 2015 Sep; 62(3):887-99. PubMed ID: 25998949
[TBL] [Abstract][Full Text] [Related]
5. Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis.
Siempos II; Dimopoulos G; Korbila IP; Manta K; Falagas ME
Eur Respir J; 2007 Jun; 29(6):1127-37. PubMed ID: 17301097
[TBL] [Abstract][Full Text] [Related]
6. A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury.
Cirulli ET; Nicoletti P; Abramson K; Andrade RJ; Bjornsson ES; Chalasani N; Fontana RJ; Hallberg P; Li YJ; Lucena MI; Long N; Molokhia M; Nelson MR; Odin JA; Pirmohamed M; Rafnar T; Serrano J; Stefánsson K; Stolz A; Daly AK; Aithal GP; Watkins PB; ;
Gastroenterology; 2019 May; 156(6):1707-1716.e2. PubMed ID: 30664875
[TBL] [Abstract][Full Text] [Related]
7. Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury.
Lucena MI; Andrade RJ; Martínez C; Ulzurrun E; García-Martín E; Borraz Y; Fernández MC; Romero-Gomez M; Castiella A; Planas R; Costa J; Anzola S; Agúndez JA;
Hepatology; 2008 Aug; 48(2):588-96. PubMed ID: 18666253
[TBL] [Abstract][Full Text] [Related]
8. Exploration of Biomarkers for Amoxicillin/Clavulanate-Induced Liver Injury: Multi-Omics Approaches.
Lee J; Ji SC; Kim B; Yi S; Shin KH; Cho JY; Lim KS; Lee SH; Yoon SH; Chung JY; Yu KS; Park HS; Kim SH; Jang IJ
Clin Transl Sci; 2017 May; 10(3):163-171. PubMed ID: 27785887
[TBL] [Abstract][Full Text] [Related]
9. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.
Teschke R
Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1169-1187. PubMed ID: 30354694
[TBL] [Abstract][Full Text] [Related]
10. Increased clinical failures when treating acute otitis media with macrolides: a meta-analysis.
Courter JD; Baker WL; Nowak KS; Smogowicz LA; Desjardins LL; Coleman CI; Girotto JE
Ann Pharmacother; 2010 Mar; 44(3):471-8. PubMed ID: 20150506
[TBL] [Abstract][Full Text] [Related]
11. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.
Björnsson ES; Bergmann OM; Björnsson HK; Kvaran RB; Olafsson S
Gastroenterology; 2013 Jun; 144(7):1419-25, 1425.e1-3; quiz e19-20. PubMed ID: 23419359
[TBL] [Abstract][Full Text] [Related]
12. Searching for a needle in a haystack: use of ICD-9-CM codes in drug-induced liver injury.
Jinjuvadia K; Kwan W; Fontana RJ
Am J Gastroenterol; 2007 Nov; 102(11):2437-43. PubMed ID: 17662100
[TBL] [Abstract][Full Text] [Related]
13. Predicting and preventing acute drug-induced liver injury: what's new in 2010?
Liss G; Rattan S; Lewis JH
Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1047-61. PubMed ID: 20615079
[TBL] [Abstract][Full Text] [Related]
14. Systematic review and meta-analysis of algorithms used to identify drug-induced liver injury (DILI) in health record databases.
Tan EH; Low EXS; Dan YY; Tai BC
Liver Int; 2018 Apr; 38(4):742-753. PubMed ID: 29193566
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.
Andrade RJ; Lucena MI; Fernández MC; Pelaez G; Pachkoria K; García-Ruiz E; García-Muñoz B; González-Grande R; Pizarro A; Durán JA; Jiménez M; Rodrigo L; Romero-Gomez M; Navarro JM; Planas R; Costa J; Borras A; Soler A; Salmerón J; Martin-Vivaldi R;
Gastroenterology; 2005 Aug; 129(2):512-21. PubMed ID: 16083708
[TBL] [Abstract][Full Text] [Related]
16. Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry.
Andrade RJ; Lucena MI; Kaplowitz N; García-Muņoz B; Borraz Y; Pachkoria K; García-Cortés M; Fernández MC; Pelaez G; Rodrigo L; Durán JA; Costa J; Planas R; Barriocanal A; Guarner C; Romero-Gomez M; Muņoz-Yagüe T; Salmerón J; Hidalgo R
Hepatology; 2006 Dec; 44(6):1581-8. PubMed ID: 17133470
[TBL] [Abstract][Full Text] [Related]
17. Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs.
Urban TJ; Shen Y; Stolz A; Chalasani N; Fontana RJ; Rochon J; Ge D; Shianna KV; Daly AK; Lucena MI; Nelson MR; Molokhia M; Aithal GP; Floratos A; Pe'er I; Serrano J; Bonkovsky H; Davern TJ; Lee WM; Navarro VJ; Talwalkar JA; Goldstein DB; Watkins PB; ; ; ; ;
Pharmacogenet Genomics; 2012 Nov; 22(11):784-95. PubMed ID: 22968431
[TBL] [Abstract][Full Text] [Related]
18. Prevention and management of idiosyncratic drug-induced liver injury: Systematic review and meta-analysis of randomised clinical trials.
Niu H; Sanabria-Cabrera J; Alvarez-Alvarez I; Robles-Diaz M; Stankevičiūtė S; Aithal GP; Björnsson ES; Andrade RJ; Lucena MI
Pharmacol Res; 2021 Feb; 164():105404. PubMed ID: 33359912
[TBL] [Abstract][Full Text] [Related]
19. [Hepatotoxicity by antibiotics: update in 2008].
Robles M; Andrade RJ
Rev Esp Quimioter; 2008 Dec; 21(4):224-33. PubMed ID: 19031123
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
